Revolution Medicines, Inc.

NASDAQ:RVMD

36.89 (USD) • At close July 1, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q4
Omzet 0261.5920000.74203.8247.01415.333.3569.1167.5789.461.1018.69810.1318.75112.66110.02511.54612.08812.50612.28113.16610.347
Kosten van de omzet 0130.796012.775118.0212.8582.1451.7732.5332.59969.4552.3342.292.06246.47345.93640.85837.00634.87132.91827.45727.4922.96220.11721.18618.181
Brutowinst 0130.7960-12.775-118.021-2.116-2.1452.0514.48112.731-66.0996.7825.2887.398-45.372-37.238-30.727-28.255-22.21-22.893-15.911-15.402-10.456-7.836-8.02-7.834
Brutowinstmarge 00.5000-2.85200.5360.6390.83-19.6960.7440.6980.782-41.21-4.281-3.033-3.229-1.754-2.284-1.378-1.274-0.836-0.638-0.609-0.757
Onderzoek- en ontwikkelingskosten 205.749187.52151.752134.932118.021146.867107.73597.98168.94766.12769.45561.00156.4953.68146.47345.93640.85837.00634.87132.91827.45727.4922.96220.11721.18618.181
Algemene en administratieve kosten 35.01128.7923.9621.71122.83832.24415.51314.6413.22410.9110.43410.2049.0378.6927.7917.2976.675.8255.3415.0915.1714.1623.1032.7252.4163.835
Verkoop- en marketingkosten 00000-1.24400000000000000000000
Verkoop-, algemene en administratieve kosten 35.01128.21423.9621.71122.8383115.51314.6413.22410.9110.43410.2049.0378.6927.7917.2976.675.8255.3415.0915.1714.1623.1032.7252.4163.835
Overige kosten 000-12.775-118.021000000000000000000000
Bedrijfskosten 240.76216.31175.712143.86822.838177.867123.248112.62182.17177.03779.88971.20565.52762.37354.26453.23347.52842.83140.21238.00932.62831.65226.06522.84223.60222.016
Bedrijfsresultaat -240.76-216.31-175.712-156.643-140.859-179.983-123.248-108.797-75.157-61.707-76.533-62.089-57.949-52.913-53.163-44.535-37.397-34.08-27.551-27.984-21.082-19.564-13.559-10.561-10.436-11.669
Bedrijfsresultaat ratio 0-0.827000-242.5650-28.451-10.715-4.025-22.805-6.811-7.647-5.593-48.286-5.12-3.691-3.894-2.176-2.791-1.826-1.618-1.084-0.86-0.793-1.128
Totaal overige inkomsten en kosten netto 27.34420.98819.42423.4124.85618.78910.94710.4997.0595.0772.9070.8670.3020.2370.2230.2360.2210.2380.330.7110.8880.5950.7410.4420.3050.33
Inkomen voor belasting -213.416-195.322-156.288-133.233-116.003-161.194-112.301-98.298-68.098-56.63-73.626-61.222-57.647-52.676-52.94-44.299-37.176-33.842-27.221-27.273-20.194-18.969-12.818-10.119-10.131-11.339
Inkomen voor belasting ratio 0-0.747000-217.2430-25.706-9.709-3.694-21.939-6.716-7.607-5.568-48.084-5.093-3.67-3.867-2.15-2.72-1.749-1.569-1.025-0.824-0.769-1.096
Belastingkosten 00.7530000.3433.867-1.773-9.592-0.123-0.297-0.867-0.302-1.8250.2230.2360.2330.3620.347-0.058-0.675-4.3730.7660.470.3350.363
Nettowinst -213.416-194.569-156.288-133.233-116.003-161.537-108.434-98.298-58.506-56.507-73.329-60.355-57.345-52.676-52.94-44.299-37.176-34.204-27.221-27.215-19.519-14.596-12.818-10.119-10.131-11.339
Nettowinstmarge 0-0.744000-217.7050-25.706-8.341-3.686-21.85-6.621-7.567-5.568-48.084-5.093-3.67-3.909-2.15-2.715-1.691-1.207-1.025-0.824-0.769-1.096
WPA (Winst Per Aandeel) -1.13-1.13-0.94-0.81-0.7-1.14-0.99-0.92-0.62-0.63-0.87-0.81-0.77-0.71-0.72-0.6-0.53-0.52-0.42-0.46-0.67-0.4-0.35-0.28-0.28-0.31
Verwaterde WPA -1.13-1.13-0.94-0.81-0.7-1.14-0.99-0.92-0.62-0.63-0.87-0.81-0.77-0.71-0.72-0.6-0.53-0.52-0.42-0.46-0.67-0.4-0.35-0.28-0.28-0.31
EBITDA -237.044-212.923-175.712-154.934-139.352-158.336-121.103-107.024-72.624-54.031-71.193-59.755-55.659-50.614-51.189-42.458-35.486-32.128-25.574-25.583-18.629-18.081-11.92-9.28-9.308-10.615
EBITDA ratio 0-0.814000-213.3910-27.987-10.354-3.525-21.214-6.555-7.345-5.35-46.493-4.881-3.503-3.671-2.02-2.552-1.613-1.496-0.953-0.756-0.707-1.026